Logo image of MD.CA

MIDLAND EXPLORATION INC (MD.CA) Stock Fundamental Analysis

TSX-V:MD - TSX Venture Exchange - CA59751U1003 - Common Stock - Currency: CAD

0.325  -0.01 (-1.52%)

Fundamental Rating

3

Overall MD gets a fundamental rating of 3 out of 10. We evaluated MD against 822 industry peers in the Metals & Mining industry. No worries on liquidiy or solvency for MD as it has an excellent financial health rating, but there are worries on the profitability. MD is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

MD had negative earnings in the past year.
MD had a negative operating cash flow in the past year.
In the past 5 years MD always reported negative net income.
In the past 5 years MD always reported negative operating cash flow.
MD.CA Yearly Net Income VS EBIT VS OCF VS FCFMD.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M

1.2 Ratios

MD has a Return On Assets of -5.31%. This is in the better half of the industry: MD outperforms 72.12% of its industry peers.
The Return On Equity of MD (-5.53%) is better than 74.30% of its industry peers.
Industry RankSector Rank
ROA -5.31%
ROE -5.53%
ROIC N/A
ROA(3y)-4.08%
ROA(5y)-3.65%
ROE(3y)-4.23%
ROE(5y)-3.79%
ROIC(3y)N/A
ROIC(5y)N/A
MD.CA Yearly ROA, ROE, ROICMD.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -1 -2 -3 -4

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for MD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MD.CA Yearly Profit, Operating, Gross MarginsMD.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2K -4K -6K -8K

8

2. Health

2.1 Basic Checks

MD does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MD has been increased compared to 1 year ago.
MD has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, MD has an improved debt to assets ratio.
MD.CA Yearly Shares OutstandingMD.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
MD.CA Yearly Total Debt VS Total AssetsMD.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

MD has an Altman-Z score of 9.52. This indicates that MD is financially healthy and has little risk of bankruptcy at the moment.
MD has a better Altman-Z score (9.52) than 76.12% of its industry peers.
There is no outstanding debt for MD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 9.52
ROIC/WACCN/A
WACC9.25%
MD.CA Yearly LT Debt VS Equity VS FCFMD.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

MD has a Current Ratio of 4.07. This indicates that MD is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 4.07, MD is doing good in the industry, outperforming 72.36% of the companies in the same industry.
A Quick Ratio of 4.07 indicates that MD has no problem at all paying its short term obligations.
The Quick ratio of MD (4.07) is better than 73.45% of its industry peers.
Industry RankSector Rank
Current Ratio 4.07
Quick Ratio 4.07
MD.CA Yearly Current Assets VS Current LiabilitesMD.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

2

3. Growth

3.1 Past

MD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -48.85%.
The Revenue for MD has decreased by -48.80% in the past year. This is quite bad
Measured over the past years, MD shows a very strong growth in Revenue. The Revenue has been growing by 42.06% on average per year.
EPS 1Y (TTM)-48.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-69.57%
Revenue 1Y (TTM)-48.8%
Revenue growth 3Y-1.2%
Revenue growth 5Y42.06%
Sales Q2Q%-83.02%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MD.CA Yearly Revenue VS EstimatesMD.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100K 200K 300K
MD.CA Yearly EPS VS EstimatesMD.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MD. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MD.CA Price Earnings VS Forward Price EarningsMD.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MD.CA Per share dataMD.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2 0.3 0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for MD!.
Industry RankSector Rank
Dividend Yield N/A

MIDLAND EXPLORATION INC

TSX-V:MD (3/7/2025, 7:00:00 PM)

0.325

-0.01 (-1.52%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)02-17 2025-02-17
Earnings (Next)05-08 2025-05-08
Inst Owners23.98%
Inst Owner ChangeN/A
Ins Owners4.84%
Ins Owner ChangeN/A
Market Cap30.43M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 180.47
P/FCF N/A
P/OCF N/A
P/B 0.74
P/tB 0.74
EV/EBITDA N/A
EPS(TTM)-0.03
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0.44
TBVpS0.44
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.31%
ROE -5.53%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-4.08%
ROA(5y)-3.65%
ROE(3y)-4.23%
ROE(5y)-3.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 9557.86%
Cap/Sales 1695.02%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.07
Quick Ratio 4.07
Altman-Z 9.52
F-Score3
WACC9.25%
ROIC/WACCN/A
Cap/Depr(3y)12561.2%
Cap/Depr(5y)13783.8%
Cap/Sales(3y)1602.19%
Cap/Sales(5y)4631.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-48.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-69.57%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-48.8%
Revenue growth 3Y-1.2%
Revenue growth 5Y42.06%
Sales Q2Q%-83.02%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-17.98%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y10.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-16.94%
OCF growth 3YN/A
OCF growth 5YN/A